Neoatricon® is a ready to use formulation with no dilution required. It is available in 1.5 mg/mL 30 mL vial and 4.5 mg/mL 50 mL for flexible dosing.

For Neoatricon Summary of Product Characteristics and Patient Information Leaflet, please click here

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints/

Refer to Summary of Product Characteristics to Know More About Neoatrion 1.5 mg/mL solution for infusion

Refer to Summary of Product Characteristics to Know More About Neoatrion 4.5 mg/mL solution for infusion